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Abstract
Vanadium (V) has recently been found to possess potent anti-neoplastic activity in rat hepatocarcinogenesis. Recent
studies have suggested that the active metabolite of vitamin D3, 1K,25-dihydroxyvitamin D3 [1,25(OH)2D3], can inhibit
growth and/or induce differentiation of a variety of cell types. In the present study, attempts have been made to investigate
the combination effects on chromosomal aberrations (CAs) and DNA-strand breaks during the early preneoplastic stage of
diethylnitrosamine (DEN)-induced rat liver carcinogenesis in male Sprague-Dawley rats. V (0.5 ppm ad libitum) and/or
1,25(OH)2D3 (0.3 Wg/0.1 ml propylene glycol per os twice weekly) either alone or in combination were given to DEN-treated
and control rats 4 weeks prior to DEN injection. Under these experimental conditions it was observed that, when given in
combination, V and 1,25(OH)2D3 offered maximum protection against DEN-induced structural aberrations 96 h (66.7%,
P6 0.05), 15 days (44.9%, P6 0.005) and 30 days (63.8%, P6 0.001) after DEN injection. Synergistic supplementation of
both V and 1,25(OH)2D3 4 weeks before DEN injection was found to offer significant (64.1%, P6 0.001) protection against
generation of single-strand breaks when compared with the DEN control. Thus, the combination effect of V, an essential
trace element, and of 1,25(OH)2D3, a dietary micronutrient, appears beneficial in preventing genetic damage in liver cells
upon alkylation induced by DEN. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The biologically active form of vitamin D3, the
nuclear hormone 1K,25-dihydroxyvitamin D3
[1,25(OH)2D3] is an important regulator of cellular
growth, di¡erentiation and death [1]. Earlier studies
have established 1,25(OH)2D3 as a potent anti-neo-
plastic agent as being an anti-proliferating as well as
di¡erentiation inducing agent [2,3]. Equally well
documented are the protective e¡ects of
1,25(OH)2D3 on carcinogen-induced colon, breast,
skin and prostate cancer in human and experimental
animals [4^7]. Though 1,25(OH)2D3 has been shown
to promote the di¡erentiation of cancer cells and cell
lines in vitro, very meager information is available of
their e¡ect in the inhibition of chemical rat liver car-
cinogenesis.
Again vanadium (V) compounds have also been
shown to possess pronounced anti-neoplastic activity
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against mouse liver tumors [8], TA3Ha murine mam-
mary adenocarcinoma [9] as well as xenografted hu-
man carcinomas of the lung, breast and gastrointes-
tinal tract [10]. Furthermore, feeding a puri¢ed diet
supplemented with vanadyl sulfate prevented the in-
duction by N-methyl-N-nitrosourea of mammary
cancers when given during the post-initiation stages
of neoplastic process [11]. Previous studies from our
laboratory have shown that V at 0.5 ppm in drinking
water was very active in preventing diethylnitros-
amine (DEN)-induced rat liver carcinogenesis [12].
Cytogenetic investigations have demonstrated that
a variety of haemopoietic malignancies are character-
ized by a speci¢c chromosomal abnormality. In the
last few years, the molecular basis of some of these
characteristic karyotypical changes has been investi-
gated and it has been demonstrated that structural
changes in chromosomes can alter the expression of
speci¢c genes located at break-points. The impor-
tance of tumor-suppressor genes has been demon-
strated where gain or loss of part or a whole chro-
mosome may result in the expression of malignancy.
The common tumor chromosome aberrations (CAs)
are generally classi¢ed as structural or numerical.
Structural alterations include translocations, inver-
sions, deletions, insertions and ampli¢cations, where-
as numerical abnormalities are losses or duplications
of whole chromosomes. Also, there are other types of
aberrations, i.e. physiological aberrations which in-
clude erosion, pulverization and stickiness. The result
is that our understanding of these malignancies in
molecular, if not biological terms, has emerged soon-
er than our understanding of the solid tumors [13].
DNA is generally considered to be the most crit-
ical cellular target of lethal carcinogenic and muta-
genic e¡ects of drugs, radiation and environmental
chemicals [14]. Alterations of the DNA helix include
helical distortion, single-strand breaks, double-strand
breaks, inter-strand crosslinks and CAs [15,16]. Ear-
lier methods for detecting DNA unwinding in alkali
have required physical separation of single- from
double-stranded DNA (DS-DNA) using a hydroxy-
apatite column, speci¢c nuclease digestion and pre-
cipitation or ¢lter binding [17]. Moreover, radiolab-
elling of cells was required for detection of the small
amounts of DNA involved. In cells where radiolab-
elling was not feasible, sensitive £uorimetric methods
were substituted to permit detection and quantitation
of DNA after column or ¢lter separation [18]. In this
study, we have used a technique of £uorimetric anal-
ysis of DNA unwinding (FADU) using a £uorescent
dye for monitoring DNA unwinding, according to
the method of Sarkar et al. [19].
In view of the acknowledged importance of CAs as
a hallmark of the stage of progression in multistage
carcinogenesis, in the present study attempts have
been made to get an insight into the critical amount
of CA involved in the early stages of hepatic neo-
plasia when DNA-strand breaks were induced by the
potent hepatocarcinogen DEN. In addition, a possi-
ble modi¢cation by V or 1,25(OH)2D3 or both com-
bined was observed.
2. Materials and methods
2.1. Animals
Male Sprague-Dawley rats weighing 80^100 mg at
the beginning of the experiment were obtained from
the Indian Institute of Chemical Biology (Calcutta,
India) and used for the experiment. They were kept
in wire mesh metal cages (5 rats/cage) at a constant
temperature of 22 þ 1‡C, relative humidity 50^60%
with a 12:12 h controlled light and dark rhythm
and provided with food and water ad libitum. Rats
were acclimatized for 1 week before the commence-
ment of the experiment. We followed the recommen-
dations of the NIH guide for the Care and Use of
Laboratory Animals for the maintenance, treatment
and killing of the animals used in this study.
2.2. Experimental protocol
2.2.1. For chromosomal aberrations
The rats were divided into eight (8) groups as de-
picted in Fig. 1. In groups B, C, D and E, hepato-
carcinogenesis was initiated by a single intraperito-
neal (i.p.) injection of DEN at a dose of 200 mg/kg
body weight in 0.9% normal saline at week 4. Nor-
mal vehicle control rats (group A) received only nor-
mal saline ones and propylene glycol (PG) for di¡er-
ent time periods. At 18^20 h after DEN or normal
saline injection, rats were subjected to 70% partial
hepatectomy (PH) under ether anesthesia. V (as am-
monium monovanadate, E. Merck, India) was sup-
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plemented at a dose of 0.5 ppm in drinking water ad
libitum [12] and 1,25(OH)2D3 (Sigma, MO, USA)
was given at a dose of 0.3 Wg/0.1 ml PG per os twice
weekly [20] for the entire period of the experiment
with the treatment starting 4 weeks before the initia-
tion with DEN. Group B rats were the DEN control,
group C rats were supplemented with V only, group
D rats were treated with 1,25(OH)2D3 only and
Fig. 1. Basic experimental regimen of chromosomal aberrations study.
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group E rats were treated with both V and
1,25(OH)2D3. Groups c, d and e served as the re-
spective V, 1,25(OH)2D3 and V plus 1,25(OH)2D3
control groups. A set of ¢ve rats each time from
each group was killed for CA analysis at 96 h, 15
and 30 days after DEN injection.
2.2.2. For DNA-strand break analysis
Rats were divided into eight (8) groups. In groups
B, C, D and E, hepatocarcinogenesis was initiated by
a single i.p. injection of DEN at a dose of 200 mg/kg
body weight in 0.9% normal saline at week 4. Nor-
mal vehicle control rats (group A) received only nor-
mal saline ones and propylene glycol. V (group C),
1,25(OH)2D3 (group D) or both V and 1,25(OH)2D3
(group E) were supplemented at the same dose regi-
men of CA analysis 4 weeks prior to DEN injection.
Groups c, d and e served as the respective V,
1,25(OH)2D3 and V plus 1,25(OH)2D3 control
groups respectively. All the rats were killed 18^20 h
after DEN injection, livers were promptly excised
and DNA was isolated.
2.3. Rat liver chromosome preparation by partial
hepatectomy
Pretreatment was performed by injecting colchi-
cine in 0.9% sodium chloride at 2 mg/kg body weight
i.p. 3 h before killing. Hepatocytes were isolated by
the procedure of Horiuchi et al. [21], which involved
incubation of ¢nely minced rat liver slices (about
1 mm3) with 0.05% collagenase (type IV) (Sigma,
USA) solution for 30 min. Then the supernatant
was carefully removed and 10 ml of Hanks’ solution
(Ca2 and Mg2 free) was added to the tissue. The
hepatocyte suspension was obtained by gently pipet-
ting the tissue up and down and then allowing it to
stand for 5 min. The supernatant was then subjected
to centrifugation at 3200Ug for 5 min. Pellets of
isolated hepatocytes were resuspended in 0.075 M
potassium chloride and kept at 37‡C for 25 min.
The KCl solution was then replaced by the ¢xative,
i.e. methanol^glacial acetic acid (3:1), which was
changed three times. After the third ¢xation, chro-
mosome slides were prepared by spreading ¢xed cells
over chilled (in 50% methanol) and grease free slides
and put through a £ame. The slides were kept over-
night under air and stained with Giemsa (3% solu-
tion, pH 5.9) for 30 min for scoring chromosomal
anomalies.
2.4. Scoring of chromosomal aberrations data
Metaphase cells with one or more types of CAs
were scored blind from at least 50 well spread meta-
phase plates per rat (i.e. 250 metaphase plates per
group) and the frequency of CAs was expressed as
the percentage of total aberrant metaphase plates.
Aberrations were classi¢ed into three major groups
^ structural, numerical and physiological according
to our previously published criteria [22].
2.5. Isolation and assay of DNA unwinding
DNA was isolated from the rat liver by a modi¢-
cation of the published criteria [23]. After isolation,
the purity of DNA solution was checked by deter-
mining the ratios of absorbance at A260/A280 and
A260/A230. The solution containing the puri¢ed
DNA was then stored at 320‡C.
The principle of DNA-strand unwinding is that
the £uorescent dye ethidium bromide (EtBr) binds
selectively to DS-DNA in the presence of single-
stranded DNA (SS-DNA) when short duplex regions
in SS-DNA molecules are destabilized by alkali treat-
ment [24].
After isolation of DNA from each experimental
and control group, the solution was divided equally
among three sets of tubes. The contribution to £uo-
rescence by components other than DS-DNA (in-
cluding free dye) is estimated from a blank sample
(B) in which the DNA solution is ¢rst sonicated
highly and then treated with alkali under conditions
which cause complete unwinding of low molecular
weight DS-DNA. A second sample is used for esti-
mating total £uorescence (T), i.e. £uorescence due to
the presence of DS-DNA with contaminants. The
di¡erence (T3B) provides an estimate of the amount
of DS-DNA in the DNA pool. A third sample (P) is
exposed to alkali conditions su⁄cient to permit par-
tial unwinding of the DNA, the degree of unwinding
being related to the size of the DNA. The £uores-
cence of the sample less than the £uorescence of the
blank (P3B) provides an estimate of the amount of
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DS-DNA remaining. Percent D is given by the equa-
tion:
Percent D  P3B6T3BU100:
2.6. Fluorimetric analysis of DNA unwinding
(FADU)
The DNA solution was ¢rst alkali denatured by
raising the pH to 12.8. After about 10 min (deter-
mined by trial experiments), the pH of the mixture
was brought down to about 9.0 by addition of an
approximate aliquot (about 1.3 ml) of an acid solu-
tion. The DNA was then mechanically sheared by
passing it (20^25 times) through a needle of 24 gauge
using a hypodermic syringe. The DNA solution was
then distributed into 15 test tubes containing 2.0 ml
of the DNA solution of OD equal to 1.8 to 1.9 at
A260/A280. The tubes were designated as T, P or B in
each group. The DNA solution in tube B was
sheared initially. To the P and B tubes, alkali solu-
tions were ¢rst added, mixed and then tubes were
incubated at 15‡C for 10 min. Denaturation was
stopped by chilling to 0‡C and addition of acid so-
lution as described earlier. An aliquot (0.2 Wl) of
EtBr solution in 0.003 M sodium hydroxide contain-
ing 96 Wg/ml EtBr was added to each tube and the
£uorescence was read at room temperature in a
Waters spectro£uorimeter (excitation at 525 nm
and emission at 591 nm). The extent of DNA un-
winding after a given time of exposure to alkali is
calculated from the £uorescence values of T, P and B
samples. The percentage of D (DS-DNA) is given by
P3B6T3BU100:
2.7. Estimation of single-strand breaks
It is assumed that the distribution of single-strand
breaks in the DNA population follows a simple Pois-
son’s law. Under these circumstances, it is possible to
make an approximate estimate of the average num-
ber of single-strand breaks (n) per DNA unit from
the simple equation [25]
e3n  D=S D
S = percentage DNA that remains single-stranded
after alkali treatments, D = percentage remaining as
duplex DNA. D/S+D represents the fraction (fo) of
the molecules without strand breaks. The values of
‘n’ corresponding to di¡erent DNA solutions isolated
from di¡erent groups were then estimated.
2.8. Statistical analysis
Data were analyzed statistically for di¡erences be-
tween the means using Student’s t-test and values of
P6 0.05 were taken to imply statistical signi¢cance.
Percent inhibition was obtained by using the formula
{(mean control3mean treatment)6mean control}U
100.
3. Results
3.1. E¡ect of vanadium and/or
1K,25-dihydroxyvitamin D3 on
DEN-induced chromosomal aberrations
Our study showed that administration of DEN to
rats resulted in an elevation of the mitotic rate in the
liver. However, it is uncertain whether this resulted
to a regenerative event in the livers caused by the
toxic e¡ect of DEN or to an initial proliferative pro-
cess in carcinogenesis. Therefore, it seems possible
that the elevation of the mitotic rate during DEN
treatment favored production and increase in the
number of cells with abnormal chromosomes. The
results (Table 1) showed that a single i.p. injection
of DEN (group B) induced a signi¢cant number of
aberrant metaphase cells in the hepatocytes observed
at 96 h (5.2%), 15 days (87.2%) or 30 days (83.2%)
following DEN injection when compared with that
of normal vehicle control (group A). Most of the
aberrations indicated a direct damaging e¡ect on
chromosomes, i.e. structural type followed by numer-
ical and physiological type aberrations. A maximum
of total percentage of structural aberrations (i.e.
fragments, breaks, constrictions, translocations,
rings) was observed 30 days post DEN treatment
(i.e. 42.0% of total 83.2% CA) followed by 15 days
post-treatment (39.2%) and 96 h (3.6%). Major phys-
iological CAs were sticky aneuploids, sticky hyper-
diploids, while major individual and exchange types
were exempli¢ed by gaps, fragments and transloca-
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Table 1
E¡ect of vanadium and/or 1K,25-dihydroxyvitamin D3 on frequency distribution of CAs in hepatocyte cells (250 plates/group) of rats treated with DEN
Time
(h/days)
Group Structural
CAs
Numerical
CAs
Physiological
CAs
Total
aberrations
Total structural aberrations
Individual type
chromatid breaks,
fragments, gaps
Exchange type
centric fusion,
translocations, rings
Aneuploidy,
polyploidy
Stickiness,
pulverization
No. No. No. No. No. % No. % Mean þ S.E.
(n = 5)
Protection
(%)
96 h A 01 00 00 00 01 0.4 01 0.4 0.02 þ 0.22
B 05 04 03 01 13 5.2 09 3.6 1.8 þ 0.42a
C 04 02 01 00 07 2.8 06 2.4 1.2 þ 0.22 33.3
D 03 02 00 01 06 2.4 05 2.0 1.0 þ 0.50 44.4
E 02 01 02 00 05 2.0 03 1.2 0.6 þ 0.27d 66.7
15 days A 01 00 01 01 03 1.2 01 0.4 0.2 þ 0.22
B 50 48 42 78 218 87.2 98 39.2 19.6 þ 1.82b
C 35 38 36 66 175 70.0 73 29.2 14.6 þ 1.79 25.5
D 31 33 32 61 157 62.8 64 25.6 12.8 þ 1.67d 34.7
E 26 28 25 50 129 51.6 54 21.6 10.8 þ 1.34f 44.9
30 days A 02 00 00 00 02 0.8 02 0.8 0.4 þ 0.27
B 55 50 47 56 208 83.2 105 42.0 21.0 þ 2.18b
C 31 27 31 37 126 50.4 58 23.2 11.6 þ 1.48c 44.8
D 26 23 21 30 100 40.0 49 19.6 9.8 þ 0.89e 53.3
E 20 18 17 22 77 30.8 38 15.2 7.6 þ 0.84g 63.8
A, normal vehicle control; B, DEN control; C, DEN+V; D, DEN+1,25(OH)2D3 ; E, DEN+V+1,25(OH)2D3.
The mean þ S.E. values of the number of structural aberrations at 96 h, 15 days and 30 days of post DEN treatment of V control (group c) was 0.0 þ 0.00, 0.2 þ 0.22
and 0.2 þ 0.22, respectively; for 1,25(OH)2D3 (group d) was 0.2 þ 0.22, 0.4 þ 0.27 and 0.4 þ 0.27, respectively and V+1,25(OH)2D3 control (group e) was 0.0 þ 0.00,
0.4 þ 0.45 and 0.2 þ 0.22, respectively. No statistical signi¢cance could be observed between these drug controls when compared with normal vehicle control (group A).
aSigni¢cantly di¡erent from normal vehicle control rats (group A) by Student’s t-test. P6 0.01.
bSigni¢cantly di¡erent from normal vehicle control rats (group A) by Student’s t-test. P6 0.001.
cSigni¢cantly di¡erent from DEN control rats (group B) by Student’s t-test. P6 0.01.
dSigni¢cantly di¡erent from DEN control rats (group B) by Student’s t-test. P6 0.05.
eSigni¢cantly di¡erent from DEN control rats (group B) by Student’s t-test. P6 0.002.
f Signi¢cantly di¡erent from DEN control rats (group B) by Student’s t-test. P6 0.005.
gSigni¢cantly di¡erent from DEN control rats (group B) by Student’s t-test. P6 0.001.
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tions, centric fusions and rings. Supplementation of
V (group C), 1,25(OH)2D3 (group D) or both in
combination (group E) which started 4 weeks before
DEN injection and continued thereafter for di¡erent
time periods markedly abated the incidence of vari-
ous CAs in the rat liver cells. It was observed that
combined supplementation of V and 1,25(OH)2D3 30
days post DEN injection in group E rats inhibit
di¡erent types of structural aberrations most signi¢-
cantly (P6 0.001) than V- and 1,25(OH)2D3-treated
groups (i.e. groups C and D respectively). Continu-
ous supplementation of both these micronutrients in
group E rats o¡ered maximum protection (66.7%,
44.9% and 63.8% at 96 h, 15 days and 30 days re-
spectively) compared to V (group C) and
1,25(OH)2D3 (group D) alone treated group. V
plus 1,25(OH)2D3 mediated protection of CAs was
predominantly re£ected in its ability to restrict both
structural as well as numerical types, irrespective of
the duration of treatment.
3.2. E¡ects of vanadium and/or
1K,25-dihydroxyvitamin D3 on DEN-induced
hepatic DNA-strand break
A signi¢cant rise in the total percentage of hepatic
DNA-strand breaks could be observed in group B
rats 20 h following a single necrogenic i.p. injection
of DEN (Table 2) when compared with normal ve-
hicle control (group A). The percentage of native
DS-DNA of group B rats was found to be 3-fold
less than in normal control rats whereas the total
aberrant single-stranded regions in group B rats
were more than 10-fold higher than that of group
A control. This dictates that the hepatocarcinogen
DEN exerted a direct damaging e¡ect on DNA.
Treatment with V or 1,25(OH)2D3 or both in combi-
nation in groups C, D and E rats respectively strictly
abated the generation of SS-DNA following DEN
injection. However, maximum protective e¡ect
against generation of single-stranded region was
found in group E that received both V and
1,25(OH)2D3. Moreover, the native DS-DNA in
group E rats was almost 2-fold higher than in group
B rats.
Table 2 also shows the number of single-strand
breaks/DNA 20 h following DEN injection in the
presence of V and 1,25(OH)2D3 either alone or in
combination. In group B, a signi¢cant (P6 0.01) in-
crease in the number of single-strand breaks/DNA
could be observed 20 h following DEN injection
when compared with that of normal vehicle control.
Treatment with V or 1,25(OH)2D3 alone showed a
decrement at the level of 53.9% and 58.6% respec-
tively (P6 0.02) but the maximum protective e¡ect
(64.0%, P6 0.01) was found in the group that re-
ceived both V and 1,25(OH)2D3 (group E).
4. Discussion
There is evidence that most neoplastic cells are
Table 2
E¡ect of vanadium and/or 1K,25-dihydroxyvitamin D3 on the number of single-strand breaks/DNA fragment in rat liver 18^20 h after
a single injection of DEN
Group Treatment(s) Percentage of
double-strand DNA
Number of single-strand breaks/DNA
fragment
Inhibition (%)
A Normal 94.75 0.07 þ 0.01a
B DEN control 32.57 1.28 þ 0.22b
C DEN+V 48.23 0.59 þ 0.07c 53.9
D DEN+1,25(OH)2D3 53.17 0.53 þ 0.05c 58.6
E DEN+V+1,25(OH)2D3 62.83 0.46 þ 0.03d 64.1
The mean value of the number of single-strand breaks/DNA fragment for V control (group c) was 0.08 þ 0.01; for 1,25(OH)2D3 con-
trol (group d), 0.09 þ 0.01 and the V+1,25(OH)2D3 control (group e), 0.10 þ 0.01. No statistical signi¢cance could be observed between
these drug controls when compared with normal vehicle control (group A).
aValues are means þ S.E.
bP6 0.01 as compared with group A.
cP6 0.02 as compared with group B.
dP6 0.01 as compared with group B.
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more genetically unstable than comparable normal
cells and that this may be a major factor contributing
to the phenomenon of clonal evolution [26]. Direct
histologic studies also suggest that genetic instability
represented by mitotic abnormalities may become
more pronounced as a neoplasm evolves. Both in
vivo and in vitro, there is evidence that neoplastic
cells may be more susceptible than comparable nor-
mal cells to chromosome breakage, non-disjunction
and ploidy changes, sister chromatid exchange (SCE)
and other genetic alterations [26,27]. CAs are consid-
ered as markers in that they occur with greatest fre-
quency in cells and tissue that are highly proliferative
[28] and somatic CAs re£ect the potential hazards to
individuals’ genetic system [29]. CAs are known to be
important somatic mutations and are clearly in-
volved in the origin, progression and diversi¢cation
of certain cancers [30], but it is di⁄cult to character-
ize the aberrations that are crucial for the event of
initiation during early stages of tumor development.
It is needless to mention that most tumors are char-
acterized by pre-determined patterns of chromoso-
mal deviation often accidentally concealed by chro-
mosomal disturbances that are associated in fact
with all malignant developments.
DEN-induced chromosome damage in the rat he-
patocytes has been etiologically implicated as one of
the early in vivo reactions [31]. A study of early
stages of hepatocarcinogenesis became possible with
the use of cell lines that were derived from rat liver
after the exposure of rats to a carcinogen for a lim-
ited time interval [32]. A minimal alteration in chro-
mosomal pattern was found to correlate with an ear-
lier preneoplastic stage as evidenced by chromosomal
analysis of DEN-induced tumorigenesis and non-tu-
morigenic rat liver cell line [33]. In this study we have
observed a random increase of CA in the group B rat
hepatocytes at various time intervals during the early
preneoplastic event following DEN-induced hepato-
carcinogenesis. Our result with respect to CA holds
good with those observed previously during the pre-
neoplasia in rat liver cells using DEN [31,34]. It was
evident from Table 1 that the ploidy level is highly
increased in group B rats and subsequent reduction
of this level in groups C, D and E which received V
or 1,25(OH)2D3 or both in combination respectively,
was observed. But the maximum percentage of
reduction was observed in group E rats which re-
ceived both V and 1,25(OH)2D3 as compared with
group B.
Another striking observation of the present study
was the V and 1,25(OH)2D3 mediated suppression of
structural as well as numerical aberrations. It has
been well established that in the majority of malig-
nant tumors, the neoplastic cells have undergone
chromosomal alterations that are still viable but are
highly complex, usually dominated by structural and
numerical aberrations [35]. Moreover, a high rate of
chromosome breakage that represent structural aber-
rations has been etiologically associated with the ini-
tiation of carcinogenic process. If the breakage le-
sions are found to be non-random and the
breakage loci happen to be those that are virtually
linked to tumorigenesis, then the probability of tu-
morigenesis would increase drastically in the target
tissue [36]. It was observed from Table 1 that V^
1,25(OH)2D3 mediated protection against structural
CAs was maximum (66.7%) at 96 h after DEN treat-
ment, decreased to 44.9% at 15 days and again in-
creased to 63.8% at 30 days post DEN treatment. It
may be that in the present study long term continu-
ous supplementation of V and 1,25(OH)2D3 can be
e¡ective in reducing the number of structural CAs.
Carcinogen-induced DNA damage, DNA repair
and SCE are similar major events during the initia-
tion stage of carcinogenesis [37]. It is well known
that DNA-strand breaks responsible for chromoso-
mal alterations are generated from DNA base lesions
induced by most chemical mutagens. The substantial
decrement of the single-strand breaks can explain
one possible mechanism of the anti-clastogenic po-
tential of V and 1,25(OH)2D3. One hypothesis is that
the in vivo protective e¡ect of V and 1,25(OH)2D3
when given together as observed here, may be due to
the excision repair activity. DNA double-strand
breaks (DDBs) are generated from mutagen-induced
DNA lesions in the S phase of the cell cycle and
repaired by post-replicational repair in the G2 phase
and that unrepaired DDBs result in breakage type
CAs [38]. In this context, the suppression of break-
age type aberrations attributed by V and
1,25(OH)2D3 in combination may be due to a mod-
i¢cation of the capability of the post-replicational
repair of DDBs.
Previous studies from our laboratory have shown
that supplementation of 0.5 ppm V for 15, 30 and 45
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days following DEN injection displayed a consider-
ably suppressed incidence of DEN evoked CAs in rat
hepatocytes [39]. Several reports suggest that antioxi-
dants suppress the clastogenic action of tumor pro-
moters and carcinogens [40]. The possible anti-clas-
togenic potential of 1,25(OH)2D3 has been neglected
thus far owing to its antioxidant potential. Recent
studies from our laboratory have established that
1,25(OH)2D3 can e¡ectively reduce the incidence of
CAs in Dalton’s lymphoma mice [41]. In this study
we have shown that the occurrences of CAs and
DDBs are greatly reduced by exploring the inhibitory
e¡ect of two anti-neoplastic agents. V plus
1,25(OH)2D3 thus may be e¡ective in o¡ering pro-
tection by two possible mechanisms: ¢rst, by pre-
venting damage to the chromosome by their sup-
pressing as well as antioxidant e⁄cacy and
secondly, by preventing the breaks at DNA by acting
on the anti-proliferative and di¡erentiation inducing
genes. Antioxidants enhance the hepatic and periph-
eral activities of several detoxi¢cation enzymes, in-
cluding glutathione S-transferase, NAD(P):H qui-
nine reductase, epoxide hydrolase and glucuronide-
conjugating systems and raise the levels of gluta-
thione and enzymes concerned with their reduction.
Antioxidants thus may protect against many carcino-
gens showing the relationship between the status of
DNA methylation and the importance of some of
enzymes associated in defense against oxidative chal-
lenge [42]. However, the exact role of antioxidant’s
ability in decreased cell proliferation and/or in-
creased DNA repair may be worthy in future course
experimentation.
Studies of the chromosomal rearrangements in
cancer have served to reinforce the view that cancer
is caused by progressive series of genetic changes.
Regardless of the mechanism, the results of this
study provide evidence that DEN-induced CA as
well as DNA-strand break can e¡ectively be inhib-
ited by the combined action of both V and
1,25(OH)2D3.
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